Zetia , Ezetrol, Ezetimibe

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

130 API Suppliers, 29 USDMF, 11 JDMF, 20 EU WC, 73 KDMF, 19 NDC API, 49 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

INTERMEDIATES

31 Intermediate Suppliers

31 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

621 FDF Dossiers, 70 FDA Orange Book, 356 Europe, 20 Canada, 25 Australia, 42 South Africa, 108 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 10MG, TABLET;ORAL - 10MG;10MG, TABLET;ORAL - 10MG;20MG, TABLET;ORAL - 10MG;40MG, TABLET;ORAL - 10MG;80MG

RELATED EXCIPIENT COMPANIES

2 Minakem, 6 SPI Pharma, 6 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 ACG Worldwide, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 19 BASF, 2 CD Formulation, 10 Corel Pharma Chem, 7 DFE Pharma, 8 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

51 Fillers, Diluents & Binders, 42 Coating Systems & Additives, 40 Disintegrants & Superdisintegrants, 34 Direct Compression, 32 Granulation, 22 Lubricants & Glidants, 19 Thickeners and Stabilizers, 19 Controlled & Modified Release, 12 Chewable & Orodispersible Aids, 10 Co-Processed Excipients, 10 Taste Masking, 9 Solubilizers, 8 Film Formers & Plasticizers, 6 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 5 Rheology Modifiers, 4 Parenteral, 4 Vegetarian Capsules, 4 Emulsifying Agents, 2 Topical, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

114 News #PharmaBuzz

114 News #PharmaBuzz

GLOBAL SALES INFORMATION

28 US Medicaid Prescriptions, 329 Regulatory FDF Prices, 41 Annual Reports

MARKET PLACE

21 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

19 US Patents, 3 US Exclusivities, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 2 Others

ANALYTICAL

6 BioAnalytical Methods

6 BioAnalytical Methods

$ Xls

Filters

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

ZyVersa Supports Emergency VAR 200 Use in Rare Amyloidosis

08 Jul 2025

// GLOBENEWSWIRE

Enforcement Report - Week of June 18, 2025

18 Jun 2025

// FDA

Scynexis Resumes Patient Dosing in Phase 3 Mario Study

28 May 2025

// GLOBENEWSWIRE

Menarini Group Announces Positive Obicetrapib Trial Data

16 Dec 2024

// PR NEWSWIRE

Sciegen`s Generics Ezetimibe & Simvastatin Receives Approval in US

10 Dec 2024

// FDA

NewAmsterdam Completes Enrollment For Obicetrapib-Ezetimibe Combo TANDEM Trial

08 Jul 2024

// GLOBENEWSWIRE

Zetia , Ezetrol, Ezetimibe

Zetia , Ezetrol, Ezetimibe

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

130 API Suppliers

29 USDMF

11 JDMF

20 EU WC

73 KDMF

19 NDC API

49 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

28 Drugs in Development

INTERMEDIATES

31 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

621 FDF Dossiers

70 FDA Orange Book

356 Europe

20 Canada

25 Australia

42 South Africa

108 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG

TABLET;ORAL - 10MG;10MG

TABLET;ORAL - 10MG;20MG

TABLET;ORAL - 10MG;40MG

TABLET;ORAL - 10MG;80MG

RELATED EXCIPIENT COMPANIES

2 Minakem

6 SPI Pharma

6 DKSH

5 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 ACG Worldwide

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

19 BASF

2 CD Formulation

10 Corel Pharma Chem

7 DFE Pharma

8 Gangwal Chemicals

4 Ideal Cures

4 Ingredion Pharma Solutions

24 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

3 Nitika Pharmaceutical Specialities

3 Novo Excipients

5 Pharmatrans-Sanaq

6 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

18 Roquette

7 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

11 Sigachi Industries

4 Silverline Chemicals

2 The Dow Chemical Company

1 Ulanqab Kema New Material

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

51 Fillers, Diluents & Binders

42 Coating Systems & Additives

TABLET;ORAL - EQ 10MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 20MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 40MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 80MG BASE;10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons